GlassScriptPhysician profile
Jordan E Grubbs
NPI 1881081982
$2,450.03
in general payments reported to CMS, 2019-2025
16 companies · $305 in 2025
The $305 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $67.38 · 2021: $375 · 2022: $377 · 2023: $1,048 · 2024: $279 · 2025: $305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,631.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,630.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $808.52 | 2022-2025 | Perclot, Preveleak, Floseal |
| Davol INC. | $365.74 | 2022-2025 | Phasix Mesh |
| Abbvie INC. | $221.68 | 2023 | |
| Novo Nordisk INC | $214.15 | 2020-2023 | |
| Intuitive Surgical, INC. | $161.80 | 2022-2023 | Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $143.97 | 2023 | Seamguard |
| Allergan, INC. | $125.00 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $111.69 | 2021 | |
| Medtronic, INC. | $82.31 | 2023 | Ligasure |
| Ethicon US, LLC | $67.97 | 2021 | |
| Tela Bio, INC. | $48.17 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Innocoll Pharmaceuticals Limited | $32.45 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $24.18 | 2023 | Seglentis |
| Boston Scientific Corporation | $15.66 | 2022 | |
| Endo Pharmaceuticals INC. | $13.94 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $12.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Grubbs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.